Taiwan Biomaterial Co., Ltd. (TPEX:6649)
49.35
+0.05 (0.10%)
Jan 22, 2026, 1:30 PM CST
Taiwan Biomaterial Company Description
Taiwan Biomaterial Co., Ltd. engages in the development and sale of implantable medical devices in Taiwan.
It offers Foamagen, a foamagen dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and nickel-titanium guidewire for guiding cerebral vascular surgery; tissue repair and regeneration products for the treatment of early osteoarthritis; and CDMO.
The company was founded in 1921 and is based in Zhubei, Taiwan.
Taiwan Biomaterial Co., Ltd.
| Country | Taiwan |
| Founded | 1921 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 35 |
| CEO | Derek Ma |
Contact Details
Address: No. 188, Shengyi Road Zhubei, 30261 Taiwan | |
| Phone | 886 3 668 3088 |
| Website | twbm.com.tw |
Stock Details
| Ticker Symbol | 6649 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006649007 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Derek Ma | General Manager |
| Yun Quan Li | Accounting Supervisor |